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Background: Acute liver failure (ALF) is a devastating clinical syndrome with a high mortality rate. The MELD score
has been implied as a prognostic tool in ALF. Hyponatremia is associated with lethal outcome in ALF. Inclusion of
serum sodium (Na) into the MELD score was found to improve its predictive value in cirrhotic patients. Therefore
the aim of this study was to determine whether inclusion of serum Na improves the predictive value of MELD in
ALF compared to established criteria.
Methods: In a prospective single center study (11/2006–12/2010), we recruited 108 consecutive ALF patients
(64% females / 36% males), who met the criteria defined by the “Acute Liver Failure Study Group Germany”. Upon
admission, clinical and laboratory data were collected, King’s College Criteria (KCC), Model of End Stage Liver
Disease score (MELD), and serum sodium based modifications like the MELD-Na score and the United Kingdom
Model of End Stage Liver Disease score (UKELD) were calculated and area under the receiver operating
characteristic curve analyses were performed regarding the prediction of spontaneous recovery (SR) or
non-spontaneous recovery (NSR; death or transplantation).
Results: Serum bilirubin was of no prognostic value in ALF, and Na also failed to predict NSR in ALF. The classical
MELD score was superior to sodium-based modifications and KCC.
Conclusions: We validated the prognostic value of MELD-Na and UKELD in ALF. Classic MELD score calculations
performed superior to KCC in the prediction of NSR. Serum Na and Na-based modifications of MELD did not further
improve its prognostic value.
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Acute liver failure (ALF) is a potentially lethal clinical
syndrome with a high mortality rate. Nonetheless, im-
mediate intensive care, specific therapies and liver trans-
plantation (LTx) have improved the prognosis of ALF
patients significantly [1-3]. According to the European
Liver Transplant registry, approximately nine percent of
LTx were related to ALF [4]. King’s college (KCC) and
Clichy criteria are etiology specific, prognosis predicting
allocation tools to warrant timely transplantation and* Correspondence: Ali.canbay@uni-due.de
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reproduction in any medium, provided the orfair organ distribution [5,6]. However, their accuracy to
reliable predict patients’ individual prognosis and to dis-
criminate those patients who will survive without LTx
remains a major challenge [7,8].
The model of end-stage liver disease (MELD), initially
established to predict survival following transjugular
intrahepatic portosystemic shunt (TIPS) procedure and
later as an allocation tool for patients with cirrhosis, has
been implied as a prognostic tool in ALF and was proven
to be superior to the KCC and Clichy criteria [9-11]. Re-
cently, various modifications of the MELD have been in-
troduced and improved accuracy in both, chronic liver
failure and ALF [12,13]. Since hepatic encephalopathy
(HE) is associated with a fulminant course of ALF and aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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an increase in brain swelling, factors that modulate fluid
osmolality were taken into account as prognostic markers
[14,15]. Patients with serum sodium between 145 and 150
mmol/l are known to have fewer episodes of intracranial
hypertension and consequently a higher risk to develop
brain edema. Thus, hyponatremia might worsen the prog-
nosis in ALF [16]. As hyponatremia is associated with poor
prognosis in cirrhosis, inclusion of serum sodium (Na)
into the MELD was found to improve its predictive value
in chronic liver diseases [13,17]. Two sodium containing
MELD modifications, “UKELD” and “MELD-Na”, were
proposed to enhance its prognostic ability in chronic liver
failure [18,19]. A potential predictive value of these modifi-
cations in ALF has not been evaluated yet.
The aim of this study was to determine whether inclu-
sion of serum sodium into the MELD score improves its
predictive value in ALF, compared to established criteria.
By evaluating these tools in a large prospective single-
center study with ALF patients, we demonstrate that the
sodium based MELD modifications do not improve the
prognostic value of the standard MELD formula.
Methods
Patients and ethical considerations
The study was carried out according to the Declaration
of Helsinki and the guidelines of the International Con-
ference for Harmonization for Good Clinical Practice, it
was approved by the local Ethics Committee of the Uni-
versity Hospital Essen (Institutional Review Board). In a
prospective monocenter study (11/2006–12/2010), we
recruited 108 consecutive ALF patients (64% females /
36% males), who met the criteria defined by the “Acute
Liver Failure Study Group Germany” [20]. In brief, ALF
was diagnosed by significant liver dysfunction with
pathologically increased laboratory parameters (bilirubin,
AST, ALT, AP, γ-GT) and an international normalized
ratio (INR) of >1.5 with the concomitant presence of any
degree of encephalopathy. Reference values for normal
ranges are presented in Table 1. A pathological increase
was defined as any value above these ranges. Other
causes of liver dysfunction were excluded, such as acute-
on-chronic liver failure or pre-existing cirrhosis. All
patients had presented within four weeks of disease on-
set without pre-existing liver disease. Upon admission,
clinical data were collected. Outcome (spontaneous re-
covery, SR; non-spontaneous recovery, NSR: comprising
transplantation or death) was defined by the status after
4 weeks post admission.
Assessment of prognosis
Serum sodium, KCC, MELD, UKELD and MELD-Na
were assessed upon admission. Parameters were corre-
lated with the outcome at 4 weeks after admission. Inorder to calculate the individual MELD score we used
the formula as published by Kamath et al. [21]. If the
bilirubin and creatinine values were below 1.0 mg/dl
they were set to 1.0 mg/dl. If the creatinine was above
4.0 mg/dl or the patients underwent dialysis during two
weeks before assessment, the creatinine value was ad-
justed to 4.0 mg/dl. In order to calculate the individual
MELD-Na score we used the formula as published by
Ruf et al. [17]. If the sodium values were below 125
mmol/l they were set to 125 mmol/l, if the values were
above 140 mmol/l they were adjusted to 140 mmol/l. In
order to calculate the individual UKELD score we used
the formula as published by Barber et al. [19]. The
KCC were evaluated following published criteria. Diffe-
rentiation between acetaminophen induced ALF and
non-acetaminophen induced ALF have been made, as
previously published [22]. Detailed formulas of the uti-
lized scores are given in Table 2.
Statistics
Differences between parameters were evaluated by one-way
Analysis of Variance, repeated-measure Analysis of Vari-
ance, or paired Student’s t-test and t-test for independent
samples t-test. For MELD and modified MELD statistics
the Mann–Whitney test was used. For categorical variables,
frequencies and percentages were estimated. χ2 or Fisher’s
exact tests were used for categorical factors. ROC calcula-
tions were undertaken where applicable. Screening, opti-
mal, and diagnostic cutoff values were calculated, and the
optimal cutoff, including specificity and sensitivity as well
as the AUC are shown in boxes included in the ROC plots.
A p < 0.05 was considered statistically significant. All values
are given as means ± standard error of means. Analyses




Mean age of the 108 patients [69 (64%) females and 39
(36%) males] was 43.4 ± 16.2 Underlying etiologies are
presented in Figure 1A. Detailed laboratory parameters
and general data are listed in Table 1. Sixty-two (60%) pa-
tients recovered spontaneously (SR), fifty-four (40%) de-
ceased or underwent LTx (NSR) (Figure 1B). Differences
concerning outcome in patients with non-acetaminophen
induced ALF are presented in Table 3.
Sodium levels fail to predict outcome in ALF
To assess the predictive value on the clinical outcome of
sodium in comparison to individual MELD parameters, we
analyzed the individual parameters at the date of the max-
imum MELD score within 4 weeks after admission. Upon
the point of maximum MELD, significant differences be-
tween SR and NSR groups were found for all of the












SR vs. NSR SR vs. † SR vs. LTx LTx vs. †
Gender female (%) 38 (58%) 31 (72%) 17 (71%) 14 (73%)
Age** 41 (64) 49 (61) 41.5 (48) 56 (54) p<0.05 p<0.05 n.s. p<0.05
BMI (kg/m2) ** 23.37 (30.59) 26.64 (46.83) 25.91 (28.54) 27.7 (42.82) n.s. n.s. n.s. n.s.
PLATELETS [/nl]** 140-380 181 (350) 165 (450) 176.5 (450) 130 (325) n.s. n.s. n.s. n.s.
GGT [U/l]** <55 113 (1102) 154 (1938) 154 (720) 158 (1938) n.s. n.s. n.s. n.s.
ALP [U/l]** 25-124 151 (3024) 183 (670) 173 (450) 214 (571) n.s. p<0.05 n.s. n.s.
AST [U/l]** <50 2329 (18650) 1081 (15388) 837 (4642) 2342 (15388) n.s. n.s. p<0.05 n.s.
ALT [U/l]** <50 2288 (12955) 1092 (7954) 946.5 (7177) 1682 (7835) p<0.05 n.s. p<0.05 n.s.
INR** 0.89-1.11 1.77 (2.96) 3.35 (8.36) 3.64 (7.88) 2.88 (8.17) p<0.05. p<0.05 p<0.05 n.s.
Direct bilirubin [mg/dl]** <0.2 5.8 (28.7) 13.8 (30) 18.25 (28) 9.3 (24.4) p<0.05 n.s. p<0.05 p<0.05
Total bilirubin [mg/dl]** 0.3-1.2 11.4 (40.5) 20.2 (43.1) 21.85 (37.7) 15.4 (38.9) p<0.05 n.s. p<0.05 p<0.05
Creatinine [mg/dl]** 0.6-1.3 0.99 (5.09) 1.81 (4.43) 1.385 (4.43) 2.5 (3.87) p<0.05 p<0.05 p<0.05 p<0.05
Sodium [mmol/l]** 136-145 138 (24) 138 (27) 137.5 (23) 139 (27) n.s. n.s. p<0.05 n.s.
MELD* 23.55 ± 0.66 36.37 ± 0.68 36.33 ± 0.8638 36.42 ± 1.12 p<0.05 p<0.05 p<0.05 n.s.
UKELD* 58.39 ± 0.57 65.12 ± 0.73 66.29 ± 0.8666 63.47 ± 1.20 p<0.05 p<0.05 p<0.05 n.s.
MELD-Na* 24.5 ± 0.65 36.49 ± 0.65 36.67 ± 0.81 36.24 ± 1.1 p<0.05 p<0.05 p<0.05 n.s.
*Mean ± Standard Error; *p<0.05 (Student’s t-Test for unrelated groups; SPSS software, version).



















Table 2 Model of end-stage liver disease (MELD) formula
and sodium dependent modifications
Score Formula
MELD MELD ¼ 10
0:957 ln creatinine mg=dl½ ð Þ
þ0:378 ln total bilirubin mg=dl½ ð Þ





MELDNa MELDNa =MELD − Na − [0.025 ×MELD × (140 − Na)] + 140
UKELD
UKELD ¼
5:395xln INRð Þð Þ
þ 1:485xln creatinine μmol=l½ ð Þð Þ
þ 3:13xln total bilirubin μmol=l½ ð Þð Þ
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NSR 3.99 ± 0.32, p < 0.05; Figure 2A), total bilirubin (SR:
Median: 11.4 Range: 40.5 [mg/dl], NSR: Median: 20.2;
Range: 43.1 Figure 2B) and creatinine (SR 1.32 ± 0.14 mg/
dl, NSR 2.15 ± 0.19 mg/dl, p < 0.05; Figure 2C). In contrast
to these findings, serum sodium did not show any differ-
ence between these two groups (SR 138.63 ± 0.57 mmol/l,A
B
Figure 1 Etiologies and Outcome of patients with ALF. A) Drug toxicity
intoxication representing 17 cases (16%) in this prospective cohort (n=108)
infection representing 18 cases. 21 ALF cases were due to miscellaneous ca
Infection). In 24 cases the underlying etiology remained indeterminate. B) M
patients died without transplantation and 24 were transplanted.NSR 138.63 ± 0.99 mmol/l; Figure 2D). Analyses of the per-
formance for the individual MELD parameters (Figure 3A)
showed that increased INR at date of maximum MELD
had a modest sensitivity and specificity (both 88%) (INR:
cutoff: 2.47, AUC: 0.922; 95% CI: 0.867-0.977; p < 0.05). In-
creased creatinine alone had a sensitivity of 75% and a spe-
cificity of 70% at a cutoff value of 1.16 mg/dl (creatinine:
AUC 0.723; 95% CI: 0.629-0.846; p < 0.05). In contrast,
serum bilirubin lacked specificity at date of maximum
MELD. However, a cutoff for serum bilirubin was calcu-
lated with an anticipated low specificity (bilirubin: cutoff:
19.8 mg/dl; AUC 0.661; 95% CI 0.54-0.774; p < 0.05). ROC
curve analysis for serum sodium revealed no significant
prognostic value.
Sodium based modifications fail to improve MELD in ALF
The classical MELD score showed a strong correlation
with the clinical outcome (Figure 3B: MELD: AUCwas the most frequent single cause ALF with acetaminophen
. Viral causes were responsible for 22 of all cases with ALF, with HBV
uses (Wilson’s disease, Amanita intoxication, Epstein-Barr-Virus-
ost patients recovered spontaneously from ALF (SR; n=65), 19
Table 3 Patient’s general characteristics and laboratory parameter by outcome in cases of non-acetaminophen induced
acute liver failure
INR Bilirubin [mg/dl] Creatinine [mg/dl] Sodium [mmol/l] MELD UKELD MELD-Na
SR N 50 50 50 49 50 49 49
Mean 1.8 14.6 1.34 138.20 23.92 58.85 24.82
Standart deviation 0.45 9.44 1.19 4.41 4.87 4.52 4.86
Standar error 0.07 1.33 0.17 0.63 0.69 0.65 0.69
Median 1.74 15.65 0.99 138.00 24.00 60 25
Skewness 1.02 0.24 2.38 −0.202 −0.126 −0.714 −0.137
NSR N 41 41 41 40 41 40 40
Mean 3.98 20.8195 2.16 138.6 36.24 65.1 36.45
Standart deviation 2.12 10.92050 1.22595 6.41233 4.53200 4.75988 4.19982
Standard error 0.33 1.71 0.19 1.01 0.71 0.75 0.66
Median 3.35 20.2 1.81 138 38 66 38
Skewness 1.56 0.43 0.56 0.89 −0.79 −0.61 −0.92
Deceased N 18 18 18 17 19 17 17
Mean 4 16.67 2.53 140.29 36.22 63.47 36.24
Standart deviation 2.292 10.53 1.23 7.48 4.93 4.96 4.53
Standard error 0.54 2.48 0.29 1.81 1.16 1.20 1.1
Median 3.12 14.85 2.45 139 39 63 38
Skewness 1.451 0.859 0.221 0.555 −0.916 −0.194 −0.985
SR vs. NSR P<0.01** P<0.01* P<0.01* n.s. p=0.732 P<0.01* P<0.01* P<0.01*
SR vs. Deceased P<0.01** n.s. P<0.01* n.s. p=0.169 P<0.01* P<0.01* P<0.01*
*p<0.05 (Student’s t-Test for unrelated groups; SPSS software, version).
**p<0.05 (Mann- Whitney- U- Test; SPSS software).
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http://www.biomedcentral.com/1471-230X/13/580.967; CI 0.935 – 0.998; p < 0.01). Since hyponatremia is
associated with an unfavorable prognosis, inclusion of
serum sodium into the MELD score was found to im-
prove its predictive value in cirrhotic patients [13,17].
However, in our ALF cohort, the classical MELD was su-
perior to sodium based modifications like the MELD-Na
(AUC: 0.960; CI: 0.924-0.966; p < 0.01) or the UKELD
(AUC: 0.828; CI: 0.738-0.918; p < 0.01).MELD and MELD-Na are more sensitive than KCC in
predicting NSR in non-acetaminophen induced ALF
A comparison of the MELD score, MELD-Na and the
KCC in non-acetaminophen induced ALF demon-
strated a better performance of the MELD based
scores (Table 4). Concerning sensitivity, specificity,
negative predictive value (NPV), positive predictive
value (PPV) and overall diagnostic accuracy, the clas-
sic MELD was superior to KCC (MELD: Sensitivity:
0.90, Specificity: 0.92, PPV: 0.90, NPV: 0.92, diagnos-
tic accuracy: 0.912; KCC: Sensitivity: 0.72, Specificity:
0.90, PPV: 0.86, NPV: 0.79, diagnositc accuracy:
0.818). While the accuracy of MELD-Na to predict
outcome was lower, compared to classic MELD score,
MELD-Na performed still better than KCC (MELD-Na: Sensitivity: 0.90, Specificity: 0.90, PPV: 0.88, NPV:
0.92 and diagnostic accuracy: 0.898).Prediction of lethal outcome for MELD and its sodium
modifications depends on the extent of liver injury
A comparison of the MELD score at time of admission
and the timepoint with a maximum MELD score within
four weeks after admission in non-acetaminophen induced
ALF revealed a better performance of the “maximum
MELD” based scores (Table 4). Concerning sensitivity, spe-
cificity, negative predictive value (NPV), positive predictive
value (PPV) and overall diagnostic accuracy the maximum
MELD values were superior to the initial ones (initial
MELD: AUC: 0.839; CI: 0.757-0.922; p < 0.01 Sensitivity:
0.78, Specificity: 0.76, PPV: 0.73, NPV: 0.81, diagnostic ac-
curacy: 0.772, initial MELD-Na: AUC: 0.825; CI: 0.738-
0.913, p<0.01 Sensitivity: 0.80, Specificity: 0.76, PPV: 0.72,
NPV: 0.83, diagnostic accuracy 0.780).Discussion and conclusion
To our knowledge, this is the first study to evaluate a po-
tential predictive role for serum sodium based MELD
modifications in the clinical setting of ALF in a large pro-
spective cohort. Compared to the individual MELD
Figure 2 Serum markers of liver damage and serum sodium in non-acetaminophen induced ALF. Standard serum parameters of liver injury
were assessed during diagnostic procedures in ALF patients, to determine status and underlying etiology. Recordings are depicted for the day of
maximum MELD score. (A) INR; (B) bilirubin; (C) creatinine; (D) sodium. All data are depicted as means ± SEM. SR: spontaneous recovery, NSR: non-
spontaneous recovery, *: p vs. NSR <0.05.
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http://www.biomedcentral.com/1471-230X/13/58parameters and in contrast to patients with chronic liver
disease or post-transplant outcomes for acute liver failure
[23], we could not find a clear association between serum
sodium levels and clinical outcome in ALF which is in line
with recent studies [24]. Accordingly, the serum sodium
based MELD modifications MELD-Na and UKELD failed
to improve the predictive value of the MELD in ALF pa-
tients. However, in our cohort the classic MELD as well as
MELD-Na was superior to KCC in predicting outcome of
ALF patients. Interestingly, hypernatremia was associated
with lethal outcome in our ALF cohort. In contrast in
chronic liver disease hyponatremia is associated with a
worse outcome even for mid to long term survival [25], the
rational for utilizing UKELD and MELD-Na in cirrhosis.
Several studies have demonstrated a good specificity for
KCC in ALF, however, the sensitivity to predict lethal out-
come was modest in the vast majority of studies, especially
in non-acetaminophen induced ALF [2,6,26]. Here, we
found a fairly good specificity for KCC to predict NSR and
as previously published only a modest sensitivity. Recent
studies identified MELD as a prognostic tool with better
sensitivity compared to KCC [21,27]. Specifically, in patients
with non-acetaminophen induced ALF, MELD was superiorto KCC in predicting outcome [9]. This is in line with our
findings, which show a better performance of MELD and
MELD-Na compared to KCC in non-acetaminophen ALF.
MELD was primarily introduced as a prognostic tool
for survival of patients with cirrhosis and portal hyper-
tension following TIPS procedure [28]. Later, it was
found to be useful in organ allocation for patients with
chronic liver disease awaiting liver transplant and is
therefore widely used in Western societies [21]. As
hyponatremia is a common clinical problem in patients
with end stage liver disease, especially in those individ-
uals with portal hypertension, ascites and hepatorenal
syndrome, sodium based modifications of the MELD
have been introduced. In the UK, the UKELD is utilized
instead of the MELD for organ allocation [19]. Murphy
et al. identified hyponatremia as an independent risk fac-
tor for brain edema, a fatal complication of ALF [16,29].
Furthermore hyponatremia has been investigated exten-
sively in the management of traumatic cerebral edema
[30,31]
In our study we could not find an advantage of sodium
based MELD modifications, compared to MELD or KCC



































































Figure 3 ROC curves for single parameters of the MELD,
sodium and different predictive scores in non-acetaminophen
induced ALF. The prognostic value of single parameters comprising
the classical MELD score was compared to serum sodium. The ROC
curve shows the prognostic value of INR, creatinine, bilirubin and
serum sodium at the point of maximum MELD during 4 weeks after
admission (A). In addition the prognostic value of the classic MELD
score was compared to sodium-based MELD modifications (UKELD
and MELD-Na) and the INR as best single prognostic parameter as
reference. Classical MELD provides the best performance of the
given scores (B). Differences in the predictive value between the
MELD and MELD-Na at the time of admission and at the time-point
of its biggest dimension (C).
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http://www.biomedcentral.com/1471-230X/13/58or hepatorenal syndrome in ALF, both common co-
morbidities of cirrhosis [32,33]. In our cohort, we did
not find a difference in sodium levels between SR and
NSR. Although Murphy et al. showed that patients with
serum sodium between 145 and 150 mmol/l had fewer
episodes of intracranial hypertension. There has been no
difference in outcome [16]. Taken together we confirm
previous publications, establishing MELD as a powerful
prognostic tool for non-acetaminophen induced ALF
patients.
Furthermore, our data revealed a crucial problem with
the assessment of any prognostic factor. We found signifi-
cant differences in its predictive value between the MELD
at the time of admission and at the time-point of its big-
gest dimension. The maximum MELD performed best in
predicting outcome in ALF, underlining the need for con-
tinuous clinical assessment of patients with ALF, given the
heterogeneity and dynamic of this disease. However, this
also shows the need for novel prognostic models and sur-
rogate parameters for the degree of liver injury and disease
progression [34]. While other possible MELD modifica-
tions might improve its accuracy in the future [12], so-
dium based MELD modifications are of little prognostic
value in the clinical setting of ALF. Remien et al., in con-
trast to other modifications of the KCC and MELD-Score,Table 4 Comparison of the predictive values, sensitivity,
specificity and diagnostic accuracy of the King’s College
Criteria, MELD and MELD-Na at the date of maximum
MELD during four weeks after admission and the MELD
at date of admission
Score Sensitivity Specificity PPV NPV Diagnostic
accuracy
Maximum MELD 0.90 0.92 0.90 0.92 0.912
KCC 0.72 0.90 0.86 0.79 0.818
MELD-Na 0.90 0.90 0.88 0.92 0.898
Initial MELD 0,78 0,76 0.73 0.81 0.772
Initial MELD-Na 0,80 0,76 0,72 0,82 0,780
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http://www.biomedcentral.com/1471-230X/13/58developed the MALD score which is novel as it builds
upon the KCC by utilizing an understanding of the dy-
namics of hepatocyte damage following APAP overdose in
the form of a dynamic mathematical model [35]. As ALF
is a devasting clinical condition, it is worth it to evaluate
new prognostic tools to improve outcome in this patients.
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